Zealand Pharma starts Phase 3 ZUPREME trials of petrelintide for chronic weight management
Bitget2026/09/22 15:00- Zealand Pharma launched the registrational Phase 3 ZUPREME program for once-weekly petrelintide in chronic weight management.
- Results have not been presented; the program is intended to generate evidence for future regulatory filings and marketing applications.
- Phase 3a comprises three placebo-controlled trials across obesity or overweight populations, including type 2 diabetes or established cardiovascular disease.
- Enrollment is expected to total about 7,000 participants, positioning petrelintide for a potential large-scale commercial opportunity.
- The decision follows earlier Phase 2 data indicating meaningful weight loss with tolerability broadly comparable to placebo.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Tesla (TSLA.US) Cybercab limited pre-orders open: priced at $29,990, with an additional monthly operating fee of $299
According to reports, Tesla has invited select customers to reserve the Cybercab, taking a step toward launching this self-driving model to general consumers.
Fed Vice Chair Sets the Tone: Inflation Is the "Most Important Signal," Interest Rate Decisions Depend on It
Federal Reserve Vice Chair Philip Jefferson stated that when policymakers consider whether to raise interest rates further, inflation has become the most important metric.
Elon Musk Leads Petition! Silicon Valley Supports Jensen Huang as Tens of Thousands Call for the Return of the Founder
Elon Musk has publicly co-signed a petition in support of Jensen Huang’s return to NVIDIA. The number of signatures on the petition website has surpassed 14,000, causing the site to almost crash due to a surge in traffic. What is raising further alarm in the capital markets is that NVIDIA’s core engineers have made collective statements, warning that if senior management mishandles the situation, key technical talent may leave, potentially undermining NVIDIA’s competitive moat.
NVIDIA (NVDA.US) downplays CEO succession rumors: no official contact with potential candidates yet, calling all speculation "premature"
Nvidia has downplayed speculation that the company is already in contact with potential CEO candidates, stating that it is still in the process of selecting a headhunting firm to seek a successor for ousted leader Jensen Huang.
Crypto prices
More
